8218.099
0.002EUR
685.56 MEUR
10.55 BEUR
1.71 B
About ASTELLAS PHARMA INC.
Sector
CEO
Naoki Okamura
Headquarters
Tokyo
Website
Employees (FY)
14.48 K
Founded
1923
ISIN
JP3942400007
FIGI
BBG000BL2GL9
Astellas Pharma, Inc. engages in the research, development, manufacture, import, and export of pharmaceutical products. Its products focus on therapeutic fields that include transplantation, immunology, infectious diseases, urology, oncology, neuroscience, diabetic complications, and metabolic diseases. The firm's global brands include Prograf, Vesicare, Protopic, Harnal, and Funguard. The company was founded by Kenji Yamanouchi in April 1923 and is headquartered in Tokyo, Japan.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on SWB exchange ASTELLAS PHARMA INC. stocks are traded under the ticker YPH.
ASTELLAS PHARMA INC. is going to release the next earnings report on Apr 25, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for ASTELLAS PHARMA INC. has a max estimate of 15.186 EUR and a min estimate of 9.112 EUR.
YPH earnings for the last quarter are −0.01 EUR per share, whereas the estimation was 0.16 EUR resulting in a −103.13% surprise. The estimated earnings for the next quarter are 0.11 EUR per share. See more details about ASTELLAS PHARMA INC. earnings.
ASTELLAS PHARMA INC. revenue for the last quarter amounts to 2.48 B EUR despite the estimated figure of 2.25 B EUR. In the next quarter revenue is expected to reach 2.49 B EUR.
Yes, you can track ASTELLAS PHARMA INC. financials in yearly and quarterly reports right on TradingView.
YPH net income for the last quarter is 93.19 M EUR, while the quarter before that showed −9.24 M EUR of net income which accounts for 1.11 K% change. Track more ASTELLAS PHARMA INC. financial stats to get the full picture.
ASTELLAS PHARMA INC. dividend yield was 3.19% in 2022, and payout ratio reached 110.62%. The year before the numbers were 2.62% and 74.53% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, YPH shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ASTELLAS PHARMA INC. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 20, 2024, the company has 14.48 K employees. See our rating of the largest employees — is ASTELLAS PHARMA INC. on this list?
We've gathered analysts' opinions on ASTELLAS PHARMA INC. future price: according to them, YPH price has a max estimate of 15.19 EUR and a min estimate of 9.11 EUR. Read a more detailed ASTELLAS PHARMA INC. forecast: see what analysts think of ASTELLAS PHARMA INC. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ASTELLAS PHARMA INC. EBITDA is 2.09 B EUR, and current EBITDA margin is 25.76%. See more stats in ASTELLAS PHARMA INC. financial statements.